Literature DB >> 9617032

Prospective evaluation of the utilization of aspirin and non-steroidal anti-inflammatory drugs in acute medical admissions.

S Pathmakanthan1, D G O'Donovan, K M Sheehan, F E Murray.   

Abstract

The aim of this study was to analyse the frequency of aspirin and NSAID usage in 400 unselected patients admitted to the general medical wards through the Accident and Emergency Department. One hundred and twenty patients (30%) reported using NSAIDs (n = 27) or aspirin (n = 99) prior to admission. The median age was 70.5 years (IQR 54-80). Most aspirin use was low dose for cardiovascular prophylaxis and headache. The reported indications for NSAID use were osteoarthritis (n = 12), rheumatoid arthritis (n = 9), gout (n = 3) and psoriatic arthritis (n = 2) and headache (n = 1). Only 23 (19%) patients were aware of the potential side effects of these agents. Co-prescribing with an H2 antagonist (n = 10), proton pump inhibitor (n = 11) or misoprostol (n = 5) was noted in 21.6%. Approximately one third of patients admitted to general medical wards in this study were receiving NSAIDs or Aspirin. The indications for prescribing were appropriate for aspirin. NSAID use was more symptom based and may have been better managed using an analgesic in some cases. Despite the high prevalence of upper gastrointestinal symptoms, co-prescribing of ulcer healing drugs was relatively uncommon.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9617032

Source DB:  PubMed          Journal:  Ir Med J        ISSN: 0332-3102


  3 in total

1.  Gastroprotection during the administration of non-steroidal anti-inflammatory drugs. A drug-utilization study.

Authors:  Alfonso Carvajal; Luis H Martín Arias; Eva Vega; José Antonio García Sánchez; Igor Martín Rodríguez; Pilar García Ortega; Javier García del Pozo
Journal:  Eur J Clin Pharmacol       Date:  2004-06-23       Impact factor: 2.953

2.  Population pharmacodynamic modelling of aspirin- and Ibuprofen-induced inhibition of platelet aggregation in healthy subjects.

Authors:  Ying Hong; Fran M Gengo; Michelle M Rainka; Vernice E Bates; Donald E Mager
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

Review 3.  Pharmacogenomics of NSAID-Induced Upper Gastrointestinal Toxicity.

Authors:  L McEvoy; D F Carr; M Pirmohamed
Journal:  Front Pharmacol       Date:  2021-06-21       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.